Consent is a game he lets you think youβre winning.
β€οΈ Synopsis. Love isnβt a choice when itβs rewritten into your very brainβwhen fear, devotion, and desire are nothing more than chemical commands. You donβt know who you were before him, only that now, you could never leave.
β‘ Book. Forbidden Fruits: Intimate Obsessions, Unhinged Desires.
β‘ Pairing. Yandere! Stepfather x Fem. Reader
β‘ Novella. Paternal Privilege – Part 7
β‘ Word Count. 1,350
β€οΈ Abstract.
The neuropsychopharmacological agent described in Paternal Privilege is a fictional compound engineered to manipulate emotional and cognitive processes through targeted biochemical interventions. While no exact counterpart exists in contemporary medical or veterinary pharmacology, the drugβs theoretical underpinnings are extrapolated from real-world substances known to modulate neurological, hormonal, and behavioral states. This research explores the scientific plausibility of such a compound, its mechanisms of action, and its inspirations from existing psychotropic and neuroactive substances.
β€οΈ Introduction.
Psychopharmacology has long sought to manipulate human cognition and behavior through chemical intervention. Existing compounds, such as benzodiazepines, selective serotonin reuptake inhibitors (SSRIs), oxytocin analogs, and certain dissociative anesthetics, demonstrate the feasibility of targeted neurochemical modulation. The drug described in Paternal Privilege functions as a multi-phase neuromodulator, selectively impairing resistance mechanisms while reinforcing attachment, dependency, and learned helplessness. This analysis explores its theoretical design by synthesizing knowledge from neurobiology, psychopharmacology, and behavioral conditioning.
β€οΈ Phase One: Neurological Recalibration.
The first phase of the drug targets specific neural structures, particularly the amygdala, prefrontal cortex (PFC), and ventral tegmental area (VTA), to create a paradoxical state of heightened fear and attachment.
β‘ Amygdala Modulation.
The amygdala, central to processing fear and emotional memory, is influenced by compounds such as Ξ²-carbolines, which act as inverse agonists at the benzodiazepine receptor sites of GABA-A receptors.
Unlike traditional anxiolytics, which enhance GABAergic inhibition, an inverse agonist induces hyperactivity, leading to increased fear sensitivity and anxiety. Comparable effects are seen in substances like FG-7142, a Ξ²-carboline derivative known to induce heightened stress responses.
By simultaneously inducing a controlled fear response while reinforcing attachment mechanisms, the drug could create dependency similar to trauma bonding seen in abusive relationships.
Real-World Use: Ξ²-carbolines are found in some plant-based hallucinogens and have been tested for experimental anxiety treatments. Substances that increase amygdala activity are used to study fear responses, PTSD, and phobia treatments. Certain interrogation drugs work by heightening fear and lowering defenses, making subjects more compliant.
β‘ Prefrontal Cortex Suppression.
To undermine rational resistance, the compound must reduce prefrontal cortical activity. The PFC regulates impulse control, logical reasoning, and executive function.
Ketamine and phencyclidine (PCP), NMDA receptor antagonists, achieve this by disrupting glutamatergic signaling, impairing cognitive processing and executive function. This effect would be fine-tuned in the fictional drug to create cognitive fog rather than full dissociation.
A controlled dampening of PFC activity could subtly reduce resistance without causing overt sedation, ensuring that the subject remains functional while experiencing increased suggestibility.
Real-World Use: Low-dose ketamine is used for depression treatment, but high doses can cause cognitive fog and detachment from reality. In psychiatric treatments, ketamine is used to “reset” certain cognitive processes in depression patients. In interrogation and manipulation, similar cognitive impairment techniques have been theorized for inducing compliance.
β‘ Ventral Tegmental Area.
The VTA, part of the mesolimbic dopamine system, is involved in reward processing and reinforcement learning. Psychostimulants (e.g., amphetamines, cocaine) artificially increase dopamine levels, creating reward-seeking behavior.
Elevating dopamine in response to the captorβs presence could create a conditioned association between compliance and neurochemical reward, reinforcing attachment.
Real-World Use: Dopaminergic drugs treat ADHD but can also cause compulsive behaviors (e.g., gambling addiction). Dopaminergic manipulation is also used in addiction treatment and behavioral therapy. Chronic exposure to dopamine-triggering situations (such as trauma bonding) reinforces learned attachment.
β‘ Learned Helplessness Induction.
Chronic stress exposure and intermittent reinforcement have been shown to condition subjects into passivity. Rodent studies demonstrate that unpredictable stressors combined with benzodiazepine withdrawal enhance learned helplessness, a phenomenon mirrored in individuals suffering from long-term trauma.
β€οΈ Phase Two: Hormonal Manipulation.
The second phase of the compound operates via controlled fluctuations in key neurotransmitters and hormones, primarily oxytocin, serotonin, and cortisol.
β‘ Oxytocin Modulation.
Oxytocin, colloquially known as the βbonding hormone,β plays a crucial role in attachment formation. Synthetic oxytocin analogs have been explored for therapeutic use, particularly in conditions like autism spectrum disorder and social anxiety.
However, elevated oxytocin can paradoxically reinforce emotional dependence, particularly when paired with a stressor. Studies on prairie voles (Microtus ochrogaster) indicate that oxytocin release during stress enhances monogamous pair bonding.
Generally, Intranasal oxytocin administration increases trust even in situations where deception is likely. The drug induces artificially elevated oxytocin levels to create an illusory sense of trust and emotional connection with the captor.
Real-World Use: Used experimentally to help autism patients with social processing. Certain abusive relationships exhibit oxytocin-mediated attachment despite mistreatment.
β‘ Serotonin Instability.
Serotonin regulates mood and emotional stability. SSRIs (e.g., fluoxetine, sertraline) can artificially stabilize mood, whereas serotonergic psychedelics (e.g., LSD, psilocybin) can induce suggestibility.
Mild serotonin depletion has been linked to increased emotional reactivity and depressive states. SSRI withdrawal effects mimic the instability described in the novel, wherein fluctuating serotonin levels lead to heightened sensitivity to both comfort and distress, reinforcing the abuserβs dual role as tormentor and savior.
By dysregulating serotonin homeostasis, the subject experiences emotional instability, leading to reliance on an external stabilizing presenceβthe captor.
Real-World Use: Antidepressants regulate serotonin, but sudden discontinuation causes instability. Controlled serotonin instability can make individuals more susceptible to external emotional influence.
β‘ Cortisol Elevation and CRH Stimulation.
Cortisol is the bodyβs primary stress hormone. Cushingβs syndrome and PTSD studies demonstrate that chronic stress alters brain function, impairing memory and increasing submissiveness.
Chronic stress exposure increases corticotropin-releasing hormone (CRH) activity, priming the brain for hypervigilance and emotional instability. This is evident in victims of prolonged abuse, where heightened CRH correlates with difficulty in emotional regulation and attachment disorders.
Fluctuating cortisol levels induce a persistent state of mild stress, reinforcing helplessness and dependency.
Real-World Use: Chronic stress increases CRH (corticotropin-releasing hormone), which heightens fear responses. Stress conditioning is observed in long-term abuse victims, where cortisol elevation reinforces dependency on an abuser.
β€οΈ Phase Three: Cognitive Conditioning.
The final phase involves targeted memory distortion and neural pathway reinforcement.
β‘ Hippocampal Interference.
The hippocampus is responsible for consolidating explicit memories.
Midazolam and scopolamine disrupt short-term memory encoding, leading to confusion and suggestibility. Also, Propranolol, a beta-blocker, has been studied for its effects on memory reconsolidation.
By disrupting noradrenergic activity during emotionally significant events, it impairs the retrieval of trauma-related memories. The fictional drug could employ a similar mechanism, selectively altering how past experiences are encoded.
The drug weakens episodic memory consolidation, causing retroactive distortionβthe subject rationalizes their compliance as self-driven rather than externally imposed.
Real-World Use: Midazolam is used in surgeries to prevent distressing memories; scopolamine has been (controversially) linked to criminal use in causing compliance. Controlled memory distortion is used in therapeutic interventions for trauma patients.
β‘ Dopaminergic Reinforcement Pathways.
Neural plasticity allows experiences to shape long-term behavior.
Dopaminergic reward circuitry underlies behavioral conditioning. Drugs such as amphetamines artificially enhance dopamine release, increasing motivation and reinforcement of learned behaviors. By subtly modulating dopaminergic transmission, the drug could strengthen neural pathways associated with submission and attachment.
Through long-term potentiation (LTP), submissive behaviors become habitual and instinctive, making reversal exceedingly difficult.
Real-World Use: Used in habit-forming therapies for Parkinsonβs and addiction treatment. Habit formation through dopaminergic reinforcement is key in addiction therapy and behavioral conditioning.
β€οΈ Delivery Mechanisms.
The fictional compoundβs administration method ensures gradual and undetectable accumulation.
β‘ Olfactory Absorption.
Volatile psychoactive agents have been explored in real-world applications, notably in military-grade incapacitating agents. Aerosolized scopolamine, for example, can be absorbed via mucous membranes, inducing suggestibility.
Real-World Use: Used in some criminal cases to induce compliance.
β‘ Dermal Penetration.
Lipophilic compounds such as fentanyl analogs are transdermally active, allowing sustained release through skin contact.
Real-World Use: Transdermal patches (e.g., nicotine, painkillers) deliver drugs gradually.
β‘ Ingestion.
Slow-release formulations akin to microdosed psychoactives ensure cumulative systemic integration without immediate sedation.
Real-World Use: Used experimentally for productivity enhancement.
β€οΈ Conclusion.
While no single drug matches the complex profile of the compound described in Paternal Privilege, its theoretical construction draws upon established pharmacological principles. By integrating elements from neuroenhancers, anxiogenics, hormonal regulators, and cognitive modifiers, such a substance could feasibly exist under controlled experimental conditions.
However, ethical considerations and existing medical regulations render its real-world application implausible outside of speculative fiction. The described mechanisms highlight both the possibilities and dangers inherent in biochemical manipulation of cognition and behavior.
β€οΈ Resources.
1. Neurological Recalibration
β’ Amygdala Modulation & Ξ²-Carbolines
β Janak, P. H., & Tye, K. M. (2015). βFrom circuits to behaviour in the amygdala.ββ―Nature,β―517(7534), 284β292.
This review covers amygdala circuitry in fear and emotional memory. It helps explain how inverse agonists at benzodiazepine sites (as with Ξ²-carboline derivatives) could heighten fear responses.
β’ Inverse Agonism and FG-7142
β Millan, M. J. (2003). βThe neurobiology and control of anxious states.ββ―Progress in Neurobiology,β―70(2), 83β244.
This work discusses the role of Ξ²-carbolines like FG-7142 as inverse agonists, detailing how they alter GABAergic tone to enhance stress responses.
β’ Prefrontal Cortex Suppression (Ketamine/PCP Effects)
β Krystal, J. H., et al. (1994). βSubanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.ββ―Archives of General Psychiatry,β―51(3), 199β214.
This study reviews how NMDA receptor antagonism impairs PFC function, supporting the concept of controlled cognitive βfog.β
β’ Ventral Tegmental Area and Dopaminergic Reinforcement
β Wise, R. A. (2004). βDopamine, learning and motivation.ββ―Nature Reviews Neuroscience,β―5(6), 483β494.
This paper explains how dopaminergic circuits (originating in the VTA) drive reward and reinforcement processes, key to understanding conditioned attachment.
β’ Learned Helplessness
β Maier, S. F., & Seligman, M. E. P. (1976). βLearned helplessness: Theory and evidence.ββ―Journal of Experimental Psychology: General,β―105(1), 3β46.
This classic paper lays the groundwork for how chronic stress and unpredictable adverse events induce a state resembling learned helplessness.
2. Hormonal Manipulation
β’ Oxytocin Modulation and Social Bonding
β Young, L. J., & Wang, Z. (2004). βThe neurobiology of pair bonding.ββ―Nature Neuroscience,β―7(10), 1048β1054.
This review details oxytocinβs role in bonding and attachment and provides insight into how elevated levels could reinforce emotional dependency.
β’ Serotonin Instability
β Harmer, C. J., et al. (2003). βAntidepressant drug treatment modifies the cognitive processing of threat in anxious patients.ββ―American Journal of Psychiatry,β―160(2), 370β373.
This study describes how alterations in serotonin can lead to mood instability, a mechanism relevant to the drugβs proposed effect on emotional reactivity.
β’ Cortisol Elevation and CRH Stimulation
β McEwen, B. S. (2007). βPhysiology and neurobiology of stress and adaptation: Central role of the brain.ββ―Physiological Reviews,β―87(3), 873β904.
McEwenβs review discusses how chronic stress and increased CRH/cortisol levels affect brain function, reinforcing states of vulnerability and dependency.
3. Cognitive Conditioning
β’ Hippocampal Interference and Memory Reconsolidation
β Nader, K., Schafe, G. E., & LeDoux, J. E. (2000). βFear memories require protein synthesis in the amygdala for reconsolidation after retrieval.ββ―Nature,β―406(6797), 722β726.
This paper highlights the disruption of memory reconsolidation, supporting the concept that interference in hippocampal processing can lead to memory distortion.
β’ Memory Distortion and Neural Plasticity
β Brunet, A., et al. (2008). βReducing PTSD symptoms with reconsolidation blockade using propranolol: A randomized controlled trial.ββ―American Journal of Psychiatry,β―165(6), 751β758.
This trial illustrates how propranolol can alter memory reconsolidation, which is analogous to the drugβs proposed mechanism for weakening traumatic memories.
β’ Dopaminergic Reinforcement and Habit Formation
β Robbins, T. W., & Everitt, B. J. (1996). βNeurobehavioural mechanisms of reward and motivation.ββ―Current Opinion in Neurobiology,β―6(2), 228β236.
This review provides insight into dopaminergic reinforcement pathways that underlie habit formation and learned behaviors.
4. Delivery Mechanisms
β’ Olfactory Absorption of Volatile Agents
β Frankenhuis, W. E. (1997). βThe nose knows: Absorption of airborne substances.β In Environmental Toxicology (pp. 123β139).
This chapter discusses how volatile psychoactive agents can be absorbed via the nasal mucosa, relevant to the proposed olfactory delivery.
β’ Dermal Penetration and Transdermal Drug Delivery
β Prausnitz, M. R., & Langer, R. (2008). βTransdermal drug delivery.ββ―Nature Biotechnology,β―26(11), 1261β1268.
This article reviews the principles and technologies behind transdermal drug delivery, providing a basis for sustained-release formulations.
β’ Ingestion and Slow-Release Formulations
β Gabrielsson, J., & Weiner, D. (2007). βPharmacokinetic and pharmacodynamic modeling of sustained release drug delivery systems.ββ―Pharmaceutical Research,β―24(6), 1089β1101.
This paper covers the design and principles of slow-release formulations, analogous to the ingestion method described for cumulative systemic integration.
ββββββββββββ
List of Fandoms and Characters
Ace Attorney: Barok van Zieks
Blue Lock: Jinpachi Ego, Michael Kaiser, Rin Itoshi, Sae Itoshi
Boku no Hero Academia: Dabi, Endeavor, Shouto Todoroki
Brutal: Satsujin Kansatsukan no Kokuhaku: N/A
Death Note: Light Yagami
Demon Slayer: Muzan Kibutsuji
Dishonored Series: Anton Sokolov, Daud
Genshin Impact: Dainsleif, Zhongli (Rex Lapis / Morax)
Haikyuu!!: Kei Tsukishima, Wakatoshi Ushijima
Honkai Star Rail: Blade, Sunday
How to Live as an Illegal Healer: N/A
Hunter x Hunter: Illumi Zoldyck
I’m Not That Kind of Talent: Duke Illuster Starbe, Nemeseus
Jujutsu Kaisen: Kenjaku, Ryomen Sukuna
Kill The Hero: Park Yong-Wan, Se Jun-Lee
Mobile Legends: Bang Bang: Aamon
Naruto Shippuden: Madara Uchiha
One Punch Man: Boros
Reverend Insanity: Fang Yuan
TOUCHSTARVED: N/A
Undertale Multiverse (Human AU): Error! Sans, Ink! Sans, Nightmare! Sans
Wuthering Waves: Geshu Lin
Your Throne: Eros Orna Vasilios
ββββββββββββ
Yandere! Stepfather & Stepdaughter
Novella 1 : Paternal Privilege
- Heβs your family, but he doesnβt act like it.
- πPleasure in every strike, pain in every kiss.
- πIn the end, love is both their salvation and their damnation.
- πHis love is suffocating, but sheβs forgotten how to breathe without it.
- πLove shouldnβt feel like drowning, but heβs the only one who can save her.
- She fell, but not by accident. He made sure of it.
β‘ A/N #1. I’m not a medical professional, so I just did my own research or this is based on my own notes on books for the past years. Heavy medical terms. I placed both my actual research when writing the story, and a more simple explanation to make things more understandable. Monkey explanation? I just combined different medicines together to form this fictional drug.
β‘ A/N #2. Hello, nice to meet you, Anon. I’m glad you enjoyed Paternal Privilege, one of the first R18 series I ever made that really helped in my later writings. You guys really like lore dumps, huh? No worries, some really ask about additional details like this. And I genuinely enjoy world building and lore, it’s why I like writing epics as well. For all of you, don’t be afraid to ask about additional lore, I really don’t mind explaining more about it. However, for this series, I will not be making it a part of the book yet itself. People ask for sequels, so consider this perhaps a minor spoiler then.
β‘ A/N #3. I had to dig through so much shiz again to see where my research went. aaghhhh, but at least it’s done. I’m so tired, haha. But, hey, free medical lesson. Not a professional but I do my research. A different kind of post, but it’s for those who love lore dumps, so here.
If you want to be added or removed from the tag list, just comment on the MASTERLIST of Forbidden Fruits (FF): Intimate Obsessions, Unhinged Desires. Thank you.
General TAG LIST of βForbidden Fruitsβ: @uniquecutie-puffs , @belovedoftheanemoarchon , @mokingbrd78k , @cooldeermagazine , @mimitk , @xileonaaaa , @acacia-koi , @purple-obsidian , @waterfal-ling , @jjune-07 , @jsprien213 , @crimson-kisses , @tinandabin , @sashakittycloud , @songbirdgardensworld , @monamuskay , @yandreams-storageblog , @tnsophiaayaonly , @ilyannailyanna , @starxvs , @iris-arcadia
β€οΈ Fang Dokja’s Books.
β‘ Book 1. A Heart Devoured (AHD): A Dark Yandere Anthology
β‘ Book 2 [you are here]. Forbidden Fruits (FF): Intimate Obsessions, Unhinged Desires.
β‘ Book 3. World Ablaze (WA) : For You, I’d Burn the World.
β‘ Book 4. Whispers in the Dark (WITD): Subtle Devotion, Lingering Shadows.
β‘ Book 5. Ink & Insight (I&I): From Dead Dove to Daydreams.
β‘ Library MASTERPOST 1. The Librarianβs Ledger: A Map to The Library of Forbidden Texts.
β‘ Disclaimer. Not all stories are included in the masterpost due to Tumblrβs link limitations. However, most long-form stories can be found here. If you’re searching for a specific yandere or theme, this guide will help you navigate The Library of Forbidden Texts. Proceed with cautionβthese tales explore obsession, madness, and devotion in their rawest forms.
ππ¨π'π¬ ππ«π¨πππ π¨π§π’π¬π 